Author

Vera Ballet 1

1 University Hospitals Leuven, Department of Gastroenterology and Hepatology, Leuven, Belgium

PROGNOSTIC FACTORS FOR LONG-TERM INFLIXIMAB TREATMENT IN CROHN?S DISEASE PATIENTS: A 20-YEAR SINGLE CENTER EXPERIENCE

Thomas Billiet, Isabelle Cleynen, Vera Ballet, Marc Ferrante, Gert Van Assche, Ann Gils, Severine Vermeire

DOSE DE-ESCALATION TO ADALIMUMAB 40 MG EVERY THREE WEEKS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A RETROSPECTIVE COHORT ANALYSIS

Sophie Van Steenbergen, Sumin Bian, Vera Ballet, Severine Vermeire, Gert Van Assche, Ann Gils, Marc Ferrante

EDUCATION OF PATIENTS WITH CROHN’S DISEASE ON THE RISKS OF SMOKING REMAINS CHALLENGING

Charlotte de Bie, Vera Ballet, Gert Van Assche, Severine Vermeire, Marc Ferrante

EFFICACY AND SAFETY OF ANTI-TNF THERAPY IN ELDERLY PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Triana Lobaton Ortega, Marc Ferrante, Vera Ballet, Paul Rutgeerts, Severine Vermeire

GENETIC AND CLINICAL CHARACTERIZATION OF 47 MULTIPLE-AFFECTED IBD FAMILIES

Alessia Settesoldi, Thomas Billiet, Eveline Hoefkens, Vera Ballet, Paul Rutgeerts, Severine Vermeire, Isabelle Cleynen

RUMINOCOCCUS GNAVUS, BACTERIODES VULGATES AND CLOSTRIDIUM PERFRINGENS PREDICT POUCHITIS FOLLOWING COLECTOMY AND IPAA IN ULCERATIVE COLITIS

Kathleen Machiels, Leen Vandermosten, Marie Joossens, Isabelle Terrasson, Vera Ballet, Marc Ferrante, Jan Verhaegen, Anthony De Buck Van Overstraeten, Albert Wolthuis, André D'Hoore, Paul Rutgeerts, Severine Vermeire, Ingrid Arijs

A DRUG-RESISTANT ASSAY CAN BETTER DIRECT THE NEED FOR ADALIMUMAB DOSE-ESCALATION AFTER INDUCTION THERAPY IN ANTI-TNF NAÏVE PATIENTS WITH CROHN’S DISEASE

Gitte Moors, Bram Verstockt, Sumin Bian, Sophie Tops, Vera Ballet, Gert Van Assche, Severine Vermeire, Ann Gils, Marc Ferrante

FC GAMMA RECEPTOR MUTATIONS FOR PREDICTION OF SUSTAINED CLINICAL REMISSION AFTER INFLIXIMAB DISCONTINUATION IN CROHN’S DISEASE PATIENTS

Mayte Arias, Marc Ferrante, Vera Ballet, Karolin Claes, Willem Wollants, Gert Van Assche, Paul Rutgeerts, Severine Vermeire

HLA-DRB1 AND THE DEVELOPMENT OF ANTIBODIES TO INFLIXIMAB IN INFLAMMATORY BOWEL DISEASE

Thomas Billiet, Niels Vande Casteele, Isabelle Cleynen, Vera Ballet, Ann Gils, Marc Ferrante, Paul Rutgeerts, Severine Vermeire

LONG-TERM OUTCOME AFTER DISCONTINUATION OF INFLIXIMAB IN PATIENTS WITH CROHN’S DISEASE ACHIEVING CLINICAL REMISSION

Niels Vande Casteele, Sophie Tops, Vera Ballet, Ann Gils, Marc Ferrante, Paul Rutgeerts, Severine Vermeire, Konstantinos Papamichail

Item 1 - 10 / 13
1
2